גאלבוס 50 מ"ג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

VILDAGLIPTIN 50 MG

Dostupno od:

NOVARTIS PHARMA SERVICES AG

ATC koda:

A10BH02

Farmaceutski oblik:

TABLETS

Administracija rute:

PER OS

Proizveden od:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapijska grupa:

VILDAGLIPTIN

Terapijske indikacije:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Datum autorizacije:

2013-11-01